Concepedia

Publication | Open Access

MELK expression in ovarian cancer correlates with poor outcome and its inhibition by OTSSP167 abrogates proliferation and viability of ovarian cancer cells

58

Citations

34

References

2017

Year

Abstract

MELK inhibition by OTSSP167 may thus present a strategy to treat patients with aggressive, progressive, and recurrent ovarian cancer.

References

YearCitations

Page 1